| Malignant Neoplasm predicts response to …PREDICTS_RESPONSE_TO200 of 234show all (up to 200) |
|---|
| in context · predicts response to | DPYD RS67376798 HOMOZYGOSITY → predicts response to Tegafur | unknown | A | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | DPYD RS67376798 HOMOZYGOSITY → predicts response to Capecitabine | unknown | A | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | DPYD RS67376798 HOMOZYGOSITY → predicts response to Fluorouracil | unknown | A | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | DPYD DPYD*13 HOMOZYGOSITYSNV → predicts response to Capecitabine | unknown | A | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | DPYD DPYD*13 HOMOZYGOSITYSNV → predicts response to Tegafur | unknown | A | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | DPYD DPYD*13 HOMOZYGOSITYSNV → predicts response to Fluorouracil | unknown | A | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | DPYD DPYD*2A HOMOZYGOSITYsplice → predicts response to Tegafur | unknown | A | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | DPYD DPYD*2A HOMOZYGOSITYsplice → predicts response to Capecitabine | unknown | A | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | DPYD DPYD*2A HOMOZYGOSITYsplice → predicts response to Fluorouracil | unknown | A | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | UGT1A1 UGT1A1*28 → predicts response to Belinostat | unknown | A | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | PTCH1 Mutationother → predicts response to Vismodegib | sensitivity | B | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ROS1 Fusionfusion → predicts response to Crizotinib | sensitivity | B | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ALK Fusionfusion → predicts response to Crizotinib | sensitivity | B | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | DNMT3A Mutationother → predicts response to Atezolizumab | resistance | B | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | DNMT3A Mutationother → predicts response to Nivolumab | resistance | B | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | DNMT3A Mutationother → predicts response to Pembrolizumab | resistance | B | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | FBXW7 Mutationother → predicts response to MTOR Inhibitor | sensitivity | B | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | CD274 Expressionexpression → predicts response to Nivolumab | sensitivity | B | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | TP53 Mutationother → predicts response to VEGF/VEGFR Inhibitors | sensitivity | B | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | PIK3CA Mutationother → predicts response to Copanlisib | sensitivity | B | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | BRAF V600ESNV → predicts response to Dabrafenib | sensitivity | B | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | BRAF V600ESNV → predicts response to Trametinib | sensitivity | B | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ALK Fusionfusion → predicts response to Entrectinib | sensitivity | B | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | NTRK3 Fusionfusion → predicts response to Entrectinib | sensitivity | B | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | TACC3 Fusionfusion → predicts response to Erdafitinib | sensitivity | B | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | FGFR2 Fusionfusion → predicts response to Erdafitinib | sensitivity | B | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | TYMS RS34743033 → predicts response to Methotrexate | unknown | B | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | SLCO1B1 N130DSNV → predicts response to Methotrexate | unknown | B | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | SLCO1B1 RS4149056SNV → predicts response to Methotrexate | unknown | B | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | KMT2A Mutationother → predicts response to Immunotherapy | sensitivity | B | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | KMT2C Mutationother → predicts response to Immunotherapy | sensitivity | B | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | MSH2 Lossdeletion_cna → predicts response to Nivolumab | sensitivity | B | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | MLH1 Lossdeletion_cna → predicts response to Nivolumab | sensitivity | B | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | PIK3CA Mutationother → predicts response to Capivasertib | sensitivity | B | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | AKT1 E17KSNV → predicts response to Capivasertib | sensitivity | B | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | UGT1A1 UGT1A1*60 → predicts response to Belinostat | unknown | B | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | BRCA2 Mutationother → predicts response to Olaparib | sensitivity | B | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | BRCA1 Mutationother → predicts response to Olaparib | sensitivity | B | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | PIK3CA E545KSNV → predicts response to Apitolisib | sensitivity | C | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | NTRK1 Fusionfusion → predicts response to Larotrectinib | sensitivity | C | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | MET Amplificationamplification → predicts response to Crizotinib | sensitivity | C | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ALK e6::e20fusion → predicts response to Crizotinib | sensitivity | C | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | PTEN Lossdeletion_cna → predicts response to Buparlisib | sensitivity | C | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | PTEN Lossdeletion_cna → predicts response to Carboplatin | sensitivity | C | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | PTEN Lossdeletion_cna → predicts response to Paclitaxel | sensitivity | C | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 Fusionfusion → predicts response to Imatinib 9 source records aggregated | resistance | D | Malignant Neoplasm | 9 | Curated | civic | graph → |
| in context · predicts response to | NTRK1 Fusionfusion → predicts response to Larotrectinib 4 source records aggregated | resistance | D | Malignant Neoplasm | 4 | Curated | civic | graph → |
| in context · predicts response to | ABL1 Fusionfusion → predicts response to Bafetinib 4 source records aggregated | resistance | D | Malignant Neoplasm | 4 | Curated | civic | graph → |
| in context · predicts response to | ABL1 Fusionfusion → predicts response to Dasatinib 4 source records aggregated | resistance | D | Malignant Neoplasm | 4 | Curated | civic | graph → |
| in context · predicts response to | EGFR L858RSNV → predicts response to Erlotinib 3 source records aggregated | sensitivity | D | Malignant Neoplasm | 3 | Curated | civic | graph → |
| in context · predicts response to | NTRK1 Fusionfusion → predicts response to Entrectinib 3 source records aggregated | resistance | D | Malignant Neoplasm | 3 | Curated | civic | graph → |
| in context · predicts response to | NTRK1 Fusionfusion → predicts response to Entrectinib 3 source records aggregated | sensitivity | D | Malignant Neoplasm | 3 | Curated | civic | graph → |
| in context · predicts response to | NTRK1 Fusionfusion → predicts response to Repotrectinib 3 source records aggregated | sensitivity | D | Malignant Neoplasm | 3 | Curated | civic | graph → |
| in context · predicts response to | RET M918TSNV → predicts response to Selpercatinib 2 source records aggregated | sensitivity | D | Malignant Neoplasm | 2 | Curated | civic | graph → |
| in context · predicts response to | KIT D816VSNV → predicts response to Imatinib 2 source records aggregated | resistance | D | Malignant Neoplasm | 2 | Curated | civic | graph → |
| in context · predicts response to | NTRK1 G595RSNV → predicts response to Entrectinib 2 source records aggregated | resistance | D | Malignant Neoplasm | 2 | Curated | civic | graph → |
| in context · predicts response to | NTRK1 F589LSNV → predicts response to Larotrectinib 2 source records aggregated | resistance | D | Malignant Neoplasm | 2 | Curated | civic | graph → |
| in context · predicts response to | NTRK1 G595RSNV → predicts response to Larotrectinib 2 source records aggregated | resistance | D | Malignant Neoplasm | 2 | Curated | civic | graph → |
| in context · predicts response to | TP53 R175HSNV → predicts response to MDM2 Inhibitor AMGMDS3 2 source records aggregated | resistance | D | Malignant Neoplasm | 2 | Curated | civic | graph → |
| in context · predicts response to | ABL1 Fusionfusion → predicts response to Dasatinib 2 source records aggregated | sensitivity | D | Malignant Neoplasm | 2 | Curated | civic | graph → |
| in context · predicts response to | ERBB2 T862ASNV → predicts response to Lapatinib | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | RET C618RSNV → predicts response to Selpercatinib | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | NTRK1 Fusionfusion → predicts response to Larotrectinib | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | NTRK1 Fusionfusion → predicts response to Entrectinib | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ERBB2 V777LSNV → predicts response to Lapatinib | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | KIT D816VSNV → predicts response to Dasatinib | resistance | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | KIT A502_Y503insAYinsertion → predicts response to Sunitinib | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | KIT V560DSNV → predicts response to Imatinib Mesylate | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | PDGFRA D842VSNV → predicts response to Imatinib Mesylate | resistance | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | KIT S628NSNV → predicts response to Imatinib | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | KIT S628NSNV → predicts response to Dasatinib | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | EGFR L858RSNV → predicts response to Dacomitinib | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | EGFR L838VSNV → predicts response to Gefitinib | resistance | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | EGFR L838VSNV → predicts response to Erlotinib | resistance | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | KIT L576PSNV → predicts response to Dasatinib | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | KIT L576PSNV → predicts response to Imatinib | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | PDGFRA D842VSNV → predicts response to Sunitinib | resistance | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | KIT V559DSNV → predicts response to Dasatinib | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | KIT V559DSNV → predicts response to Sunitinib | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | KIT V559DSNV → predicts response to PD-180970 | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | KIT V559DSNV → predicts response to Tandutinib | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | KIT V559DSNV → predicts response to Imatinib | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ERBB2 T798MSNV → predicts response to Lapatinib | resistance | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ERBB2 L755PSNV → predicts response to Lapatinib | resistance | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ERBB2 L755SSNV → predicts response to Lapatinib | resistance | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | PDGFRA D842VSNV → predicts response to Imatinib | resistance | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ERBB2 H878YSNV → predicts response to Lapatinib | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ERBB2 N857SSNV → predicts response to Lapatinib | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ERBB2 V773ASNV → predicts response to Lapatinib | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ALK Fusionfusion → predicts response to Crizotinib | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ALK Fusionfusion → predicts response to Ceritinib | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ALK G1269ASNV → predicts response to Ceritinib | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ALK Fusionfusion → predicts response to Brigatinib | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ALK G1269ASNV → predicts response to Brigatinib | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ALK F1245CSNV → predicts response to Crizotinib | resistance | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ALK Fusionfusion → predicts response to Crizotinib | resistance | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | MTOR E1799KSNV → predicts response to Sirolimus | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | MTOR C1483YSNV → predicts response to Sirolimus | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | MTOR S2215YSNV → predicts response to Sirolimus | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | TUBB3 EXPRESSIONexpression → predicts response to Paclitaxel | resistance | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | FGFR3 N540KSNV → predicts response to Futibatinib | resistance | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | TACC3 Fusionfusion → predicts response to Erdafitinib | resistance | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | TACC3 Fusionfusion → predicts response to Futibatinib | resistance | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | FGFR3 N540KSNV → predicts response to Erdafitinib | resistance | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | NTRK1 G667CSNV → predicts response to Larotrectinib | resistance | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | NTRK1 F589LSNV → predicts response to Entrectinib | resistance | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | NTRK1 G667CSNV → predicts response to Entrectinib | resistance | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | NTRK1 F589LSNV → predicts response to Entrectinib | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | NTRK1 F589LSNV → predicts response to Repotrectinib | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | NTRK1 G595RSNV → predicts response to Repotrectinib | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | FGFR3 Overexpressionexpression → predicts response to R3Mab | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | IDH1 R132CSNV → predicts response to Olaparib | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | NTRK2 Fusionfusion → predicts response to Entrectinib | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | NTRK2 Fusionfusion → predicts response to Entrectinib | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | NTRK2 Fusionfusion → predicts response to Entrectinib | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | NTRK1 Fusionfusion → predicts response to Entrectinib | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | NTRK3 G623RSNV → predicts response to ALK/TRK Inhibitor TSR-011 | resistance | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | NTRK3 G623RSNV → predicts response to Crizotinib | resistance | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | NTRK3 G623RSNV → predicts response to Entrectinib | resistance | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | NTRK3 G623RSNV → predicts response to Larotrectinib | resistance | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | NTRK3 Fusionfusion → predicts response to Crizotinib | resistance | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | NTRK3 Fusionfusion → predicts response to ALK/TRK Inhibitor TSR-011 | resistance | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | NTRK3 Fusionfusion → predicts response to Larotrectinib | resistance | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | NTRK3 Fusionfusion → predicts response to Entrectinib | resistance | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | EGFR G598VSNV → predicts response to Erlotinib | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ATRX Deletiondeletion → predicts response to Cisplatin | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ATRX Deletiondeletion → predicts response to Fluorouracil | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 H396PSNV → predicts response to Dasatinib | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 G250ESNV → predicts response to Dasatinib | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 G250ESNV → predicts response to Bafetinib | resistance | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 G250ESNV → predicts response to Imatinib | resistance | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 M244VSNV → predicts response to Bafetinib | resistance | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 M244VSNV → predicts response to Imatinib | resistance | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 Q252HSNV → predicts response to Bafetinib | resistance | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 Q252HSNV → predicts response to Imatinib | resistance | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 Y253FSNV → predicts response to Imatinib | resistance | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 H396PSNV → predicts response to Imatinib | resistance | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 F317VSNV → predicts response to Dasatinib | resistance | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 T315ASNV → predicts response to Dasatinib | resistance | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 T315ASNV → predicts response to Imatinib | resistance | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 M351TSNV → predicts response to Imatinib | resistance | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 F317LSNV → predicts response to Dasatinib | resistance | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 F317LSNV → predicts response to Imatinib | resistance | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | MET Exon 14 Skipping Mutationdeletion_cna → predicts response to Capmatinib | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | TP53 R158LSNV → predicts response to MDM2 Inhibitor AMGMDS3 | resistance | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | TP53 R158HSNV → predicts response to MDM2 Inhibitor AMGMDS3 | resistance | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | TP53 M237ISNV → predicts response to MDM2 Inhibitor AMGMDS3 | resistance | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | EGFR Y801HSNV → predicts response to Erlotinib | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | EGFR C797YSNV → predicts response to Erlotinib | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | EGFR T785ASNV → predicts response to Erlotinib | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | EGFR E734QSNV → predicts response to Erlotinib | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | EGFR W731LSNV → predicts response to Erlotinib | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | EGFR E868GSNV → predicts response to Erlotinib | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | EGFR R831HSNV → predicts response to Erlotinib | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | EGFR L858RSNV → predicts response to Multikinase Inhibitor AEE788 | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | EGFR L858RSNV → predicts response to Gefitinib | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | EGFR T790MSNV → predicts response to Gefitinib | resistance | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | EGFR T790MSNV → predicts response to Multikinase Inhibitor AEE788 | resistance | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | EGFR T790MSNV → predicts response to Erlotinib | resistance | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 Fusionfusion → predicts response to Nilotinib | resistance | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 T315ISNV → predicts response to Bafetinib | resistance | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 T315ISNV → predicts response to Dasatinib | resistance | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 T315ISNV → predicts response to Imatinib | resistance | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 T315ISNV → predicts response to Nilotinib | resistance | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 Fusionfusion → predicts response to Imatinib | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 M244VSNV → predicts response to Imatinib | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | PIK3CA Mutationother → predicts response to Capivasertib | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | PTEN Lossdeletion_cna → predicts response to Capivasertib | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | PTEN Mutationother → predicts response to Ipatasertib | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ALK Fusionfusion → predicts response to Alectinib | resistance | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ALK G1269ASNV → predicts response to Alectinib | resistance | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ALK Fusionfusion → predicts response to Brigatinib | resistance | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ALK G1202RSNV → predicts response to Brigatinib | resistance | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ALK Fusionfusion → predicts response to Alectinib | resistance | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ALK G1202RSNV → predicts response to Alectinib | resistance | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | BRAF L485_P490deldeletion → predicts response to Pan-RAF Inhibitor LY3009120 | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | NRAS Mutationother → predicts response to Trametinib | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | NRAS Mutationother → predicts response to Metformin | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | KRAS Mutationother → predicts response to AZD5438 | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | KRAS G12CSNV → predicts response to ARS-853 | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | KRAS G12CSNV → predicts response to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ERBB3 Overexpressionexpression → predicts response to Selumetinib | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ERBB3 Overexpressionexpression → predicts response to Afatinib | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | BRAF V600ESNV → predicts response to Cobimetinib | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | KRAS Mutationother → predicts response to G-573 | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | KRAS Mutationother → predicts response to MEK Inhibitor GDC-0623 | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | DUSP6 EXPRESSIONexpression → predicts response to Trametinib | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | NAPRT Promoter Hypermethylationepigenetic → predicts response to GNE-617 | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | NRG1 Expressionexpression → predicts response to Anti-ErbB3 Monoclonal Antibody AV-203 | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | CD44 CD44s Expressionexpression → predicts response to RG7356 | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | MET Exon 14 Skipping Mutationdeletion_cna → predicts response to Crizotinib | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | HRAS G12VSNV → predicts response to Binimetinib | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | HRAS G12VSNV → predicts response to Selumetinib | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | HRAS G12VSNV → predicts response to Everolimus | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | HRAS G12VSNV → predicts response to MTOR Kinase Inhibitor AZD8055 | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | HRAS G12VSNV → predicts response to Mirdametinib | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | HRAS Q61RSNV → predicts response to Binimetinib | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | HRAS Q61RSNV → predicts response to Selumetinib | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | HRAS Q61RSNV → predicts response to MTOR Kinase Inhibitor AZD8055 | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | HRAS Q61RSNV → predicts response to Everolimus | sensitivity | D | Malignant Neoplasm | 1 | Curated | civic | graph → |